The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

8026–8050 of 17974

  • SevereFDA (Drugs)·D-1148-2019·2019-04-24

    FDA Recalls HCG 20 Day Injection Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling HCG 20 Day Injection vials nationwide due to a lack of sterility assurance.

    Product
    HCG 20 Day Injection, 2625 Units/4 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1175-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Sermorelin Vials Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling 22 vials of Sermorelin 0.3 mg/0.5 mL nationwide due to a lack of sterility assurance.

    Product
    Sermorelin 0.3 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1162-2019·2019-04-24

    Methylcobalamin Injection Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Methylcobalamin 1 mg/mL Injection vials due to a lack of sterility assurance.

    Product
    Methylcobalamin 1 mg/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1168-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Prostaglandin Vials Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling 23 vials of Prostaglandin 20 mcg/mL due to a lack of sterility assurance. The product was distributed nationwide.

    Product
    Prostaglandin 20 mcg/mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1177-2019·2019-04-24

    Serum Tears 20% Drops Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Serum Tears 20% Drops due to a lack of sterility assurance. All lots of the 1 mL droptainers are affected.

    Product
    Serum Tears 20% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1170-2019·2019-04-24

    Prostaglandin Vials Recalled Due to Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Prostaglandin 60 mcg/mL vials nationwide due to a lack of sterility assurance.

    Product
    Prostaglandin 60 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1196-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls HCG Injection Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling HCG 11,000 mcg Injection vials nationwide due to a lack of sterility assurance.

    Product
    HCG 11,00Units/B 12 11,000 mcg Injection, 30 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1194-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Heparin and Marcaine Syringes for Sterility Concerns

    Anderson Compounding Pharmacy is recalling Heparin and Marcaine syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.

    Product
    Heparin 10 mL/Marcaine 0.25% 20 mL/Sodium Bicarbonate 40 mL/Normal Saline 5 mL per 75 mL, 60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1188-2019·2019-04-24

    Lidocaine Injection Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Lidocaine 1%/Dextrose 12.5% Injection vials due to a lack of sterility assurance.

    Product
    Lidocaine 1%/Dextrose 12.5% (PF) Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1176-2019·2019-04-24

    Sermorelin Injection Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Sermorelin 0.4 mg/0.5 mL vials nationwide due to a lack of sterility assurance.

    Product
    Sermorelin 0.4 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1197-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Papaverine and Phentolamine Vials

    Anderson Compounding Pharmacy is recalling Papaverine 30 mg/Phentolamine 0.5 mg/mL vials due to a lack of sterility assurance.

    Product
    Papaverine 30 mg/Phentolamine 0.5 mg/mL, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1142-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls DMSO and Heparin Syringes for Sterility Concerns

    Anderson Compounding Pharmacy is recalling DMSO 50% and Heparin syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.

    Product
    DMSO 50% 60 mL/Heparin 1 mL/ Sodium Bicarbonate 60 mL/ Solu-Cortef 100 mg, 41 mL syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1146-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls HCG Injection Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling HCG 1,000 U/mL Injection vials nationwide due to a lack of sterility assurance.

    Product
    HCG 1,000 U/mL Injection, 30 mL, Vial Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1147-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls HCG Vials Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling HCG 11,000 Units vials nationwide because the product lacks sterility assurance.

    Product
    HCG 11,000 Units, 30 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1171-2019·2019-04-24

    Prostaglandin Injection Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Prostaglandin Quad-Mix Injection vials due to a lack of sterility assurance.

    Product
    Prostaglandin Quad-Mix 20:30:1:0.15 Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1161-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Methionine Injection Due to Sterility Concerns

    Anderson Compounding Pharmacy is recalling 276 vials of a methionine and choline injection nationwide due to a lack of sterility assurance.

    Product
    Methionine 15mg/Choline 100mg/ Inositol 50mg/ Methylcobalamin 1mg/ Lidocoaine 10 mg, benzyl alcohol/ water, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1189-2019·2019-04-24

    FDA Recalls EDTA 1% Sterile Injection Due to Sterility Assurance Issues

    Anderson Compounding Pharmacy is recalling EDTA 1% Sterile Injection (Preservative Free) nationwide due to a lack of sterility assurance.

    Product
    EDTA 1% Sterile Injection (Preservative Free), Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1193-2019·2019-04-24

    Gentamicin Sterile Water Recall Due to Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Gentamicin 240 mg/500 mL Sterile Water for Irrigation due to a lack of sterility assurance.

    Product
    Gentamicin 240 mg/500 mL Sterile Water for Irrigation,60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1125-2019·2019-04-24

    InvaGen Recalls Testosterone Cypionate Injection Due to Particulate Matter

    InvaGen Pharmaceuticals is recalling Testosterone Cypionate Injection vials due to the presence of particulate matter. The affected lots were distributed nationwide in the U.S.A.

    Product
    TESTOSTERONE CYPIONATE — TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1205-2019·2019-04-24

    Teva Recalls Subpotent Amoxicillin Oral Suspension Bottles Nationwide

    Teva Pharmaceuticals is recalling specific lots of Amoxicillin Oral Suspension because assay results were below specification limits. The affected bottles were distributed nationwide and in Puerto Rico.

    Product
    Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle (NDC 0093-4150-79), Rx Only, Manufactured in Canada By: Teva Canada Limited Toronto, Canada, M1B2K9, Manufactured For: Teva Pharmaceuticals USA, INC. North Wale
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1143-2019·2019-04-24

    Anderson Compounding Pharmacy Recalls Estradiol Cypionate Vials for Sterility Concerns

    Anderson Compounding Pharmacy is recalling 35 vials of Estradiol Cypionate 10 mg/mL due to a lack of sterility assurance. The product was distributed nationwide.

    Product
    Estradiol Cypionate 10 mg/mL, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1163-2019·2019-04-24

    Methylprednisolone Ophthalmic Drops Recalled for Lack of Sterility Assurance

    Anderson Compounding Pharmacy is recalling Methylprednisolone 1% PF Ophthalmic drops due to a lack of sterility assurance. The recall covers all lots distributed nationwide.

    Product
    Methylprednisolone 1% PF Ophthalmic, 3 mL Droppers, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1133-2019·2019-04-24

    Dr. Reddy's Recalls Divalproex Sodium Tablets Due to Humidity Exposure

    Dr. Reddy's Laboratories is recalling Divalproex Sodium Extended-Release Tablets because they were exposed to high humidity during packaging.

    Product
    Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-1123-2019·2019-04-24

    InvaGen Recalls Testosterone Cypionate Injection Due to Particulate Matter

    InvaGen Pharmaceuticals is recalling specific lots of Testosterone Cypionate Injection because they contain particulate matter.

    Product
    TESTOSTERONE CYPIONATE — TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
    Category
    Drug
    Distribution
    Distributed nationwide